Patent ID: 7442712
Filing Date: 2008-10-28
Classification: A61P,C07D

Abstract:
1. A compound represented by the structural formula or a pharmaceutically acceptable salt or solvate thereof, wherein: the single-dashed line  between the ring carbons to which R the double-dashed line between X and the carbon to which Y is attached represents a single bond; X is —O—; R Y is (O), (S), (H, H), (H, OH) or (H, C Z is selected from the group consisting of —CH n n n n R is 1 to 3 substituents independently selected from the group consisting of H, C R R wherein the Het group is optionally substituted by W, wherein W is selected from the group consisting of aryl optionally substituted by halo or CN; R R R R R R R R R R or R R R R R R R R R R R R R or R R or R R R R R R